MedMira (MedMira) Scaled Net Operating Assets : -1.78 (As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is MedMira Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

MedMira's operating assets for the quarter that ended in Jan. 2024 was $2.69 Mil. MedMira's operating liabilities for the quarter that ended in Jan. 2024 was $8.66 Mil. MedMira's Total Assets for the quarter that ended in Oct. 2023 was $3.35 Mil. Therefore, MedMira's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2024 was -1.78.

MedMira Scaled Net Operating Assets Historical Data

The historical data trend for MedMira's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Scaled Net Operating Assets Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Scaled Net Operating Assets

Get a 7-Day Free Trial

-16.65

-15.56

-1.33

-1.02

-1.48

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-1.27	-1.29	-1.54	-1.97	-1.78

Competitive Comparison of MedMira's Scaled Net Operating Assets

For the Biotechnology subindustry, MedMira's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMira's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where MedMira's Scaled Net Operating Assets falls into.

MedMira Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

MedMira's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jul. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jul. 2023 )
=	(Operating Assets (A: Jul. 2023 )	-	Operating Liabilities (A: Jul. 2023 ))	/	Total Assets (A: Jul. 2022 )
=	(2.754	-	7.125)	/	2.961
=	-1.48

where

	Operating Assets		(A: Jul. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2.764	-	0.01
=	2.754

	Operating Liabilities		(A: Jul. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	14.142	-	2.238	-	4.779
=	7.125

MedMira's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jan. 2024 )
=	(Operating Assets (Q: Jan. 2024 )	-	Operating Liabilities (Q: Jan. 2024 ))	/	Total Assets (Q: Oct. 2023 )
=	(2.69	-	8.656)	/	3.345
=	-1.78

where

	Operating Assets		(Q: Jan. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.326	-	0.636
=	2.69

	Operating Liabilities		(Q: Jan. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	15.307	-	1.969	-	4.682
=	8.656

MedMira Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of MedMira's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.